SALL1, a causative gene for Townes-Brocks syndrome, encodes a zinc finger protein, and its mouse homolog (Sall1) is essential for metanephros development, as noted during gene targeting. In the embryonic kidney, Sall1 is expressed abundantly in mesenchyme-derived structures from condensed mesenchyme, S-, comma-shaped bodies, to renal tubules and podocytes. We generated mice in which a green fluorescent protein (GFP) gene was inserted into the Sall1 locus and we isolated the GFP-positive population from embryonic kidneys of these mice by fluorescein-activated cell sorting. The GFP-positive population indeed expressed mesenchymal genes, while the negative population expressed genes in the ureteric bud. To systematically search for genes expressed in the mesenchyme-derived cells, we compared gene expression profiles in the GFP-positive and -negative populations using microarray analysis, followed by in situ hybridization. We detected many genes known to be important for metanephros development including Sall1, GDNF, Raldh2, Pax8 and FoxD1, and genes expressed abundantly in the metanephric mesenchyme such as Unc4.1, Six2, Osr-2 and PDGFc. We also found groups of genes including SSB-4, Smarcd3, m-Crystallin, TRB-2, which are not known to be expressed in the metanephric mesenchyme. Therefore a combination of microarray technology and Sall1-GFP mice is useful for systematic identification of genes expressed in the developing kidney.
Introduction
In the mammalian kidney there are stromal cells, glomeruli, proximal and distal tubules, loops of Henle and collecting ducts, but all these components originate from only two types of tissues, epithelium of the ureteric bud and the metanephric mesenchyme. Around E11 in mice, the metanephric mesenchyme induces the ureteric bud to invade the metanephric mesenchyme and branch. Upon reciprocal induction by the ureteric bud, the mesenchymal cells aggregate and form blastema around the ureteric bud. The blastema develops into epithelial cells that form the nephron. The region of the metanephric mesenchyme diminishes gradually until 7 days after birth, and kidney development is complete when the metanephric mesenchyme disappears. Metanephric mesenchymal cells differentiate into at least three distinct cell types; glomerular, proximal and distal tubule epithelia as noted in retroviral mediated lac-Z gene transfer assay (Herzlinger et al., 1992) , demonstrating that the metanephric mesenchyme represents multipotent progenitor cells of the nephron.
Molecular mechanisms of kidney development have been determined mostly by gene targeting, and many mesenchymal genes including WT1, Eya1, GDNF and Six1 are known to have important roles in kidney development. The transcription factor WT1 is first expressed in the metanephric mesenchyme before induction, and in WT1 null mutant mice the ureter never reaches the mesenchyme and consequently the mesenchyme undergoes apoptosis (Kreidberg et al., 1993) . The transcriptional coactivator Eya1 is only expressed in the metanephric mesenchyme and Eya1 2 /2 mice show renal agenesis and their posterior intermediate mesoderm fails to produce the glial-derived neurotrophic factor (GDNF) (Xu et al., 1999; Buller et al., 2001) . GDNF has been identified as a mesenchyme-derived signal that acts on the receptor tyrosine kinase (Ret) and Gfra1 coreceptor which are distributed in the ureteric epithelium and induces it to produce a ureteric bud which invades the metanephric mesenchyme (Sainio et al., 1997) . Indeed, the null mutants of GDNF, Ret and Gfra1 show a similar perturbation of ureteric bud outgrowth (Schuchardt et al., 1994; Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996; Cacalano et al., 1998) . The homeodomain transcriptional factor Six1 is expressed in the metanephric mesenchyme before and after induction, and Six1-knockout mice lack kidneys because of a failure of metanephric induction (Xu et al., 2003) .
Sall1 is also expressed in the metanephric mesenchyme prior to bud invasion and continues in the induced condensing mesenchyme around ureteric bud tips and cells of mesenchymal origin. Sall1 is the mouse homologue of Drosophila sal that is the region-specific homeotic gene characterized by unique multiple double zinc finger motifs (Kuhnlein et al., 1994) . Humans and mice have at least four sal-related genes, respectively (SALL1, -2, -3 and -4 for humans and Sall1, -2, -3 and -4 for mice) (Kohlhase et al., 1996 (Kohlhase et al., , 1999 (Kohlhase et al., , 2000 (Kohlhase et al., , 2002 . SALL1 is located on chromosome 16q12.1, and heterozygous mutations of SALL1 lead to Townes-Brocks syndrome, an autosomal-dominant disease with features of dysplastic ears, preaxial polydactyly, imperforate anus and, less commonly, kidney and heart anomalies (Kohlhase et al., 1998) . Mice deficient in Sall1 die in the perinatal period, and kidney agenesis or severe dysgenesis are present (Nishinakamura et al., 2001) . Homozygous deletion of Sall1 results in an incomplete ureteric bud outgrowth and failure of tubule formation in the mesenchyme. Therefore, Sall1 is essential for ureteric bud invasion, the initial key step in metanephros development.
At present only about 20 genes are known to have important roles for kidney development and the genetic cascade of kidney development is still largely unknown. Therefore there may exist unknown mesenchymal genes that are essential for kidney development and an efficient screening assay such as microarray analysis is needed to identify these genes. We did a microarray analysis with mesenchymal cells of Sall1-GFP knockin mice isolated by fluorescein-activated cell sorting (FACS). In this report we show that the combination of microarray analysis and Sall1-GFP knockin mice, is useful for identifying many mesenchymal genes.
Results

Generation of Sall1-GFP knockin mice
To label Sall1-expressing cells, green fluorescence protein (GFP) was knocked in the Sall1 locus by homologous recombination. GFP was inserted into the Eco RI site of exon 2 so that N-terminal 52 amino acids of Sall1 were fused in frame to GFP (Fig. 1A ). Mice were genotyped using Southern blots (data not shown). This strategy is essentially the same as those used for Sall1-del and Sall1-LacZ mice that we reported, and all homozygous mice showed kidney agenesis or severe dysgenesis (data not shown). In contrast, heterozygous mice were phenotypically normal and were used for this study.
Expression pattern of GFP fluorescence in Sall1-GFP knockin kidneys
Prominent fluorescence of GFP was visible through the surface of brains, kidneys and limb buds of embryonic Sall1-GFP heterozygous mice. Microscopic analysis of the frozen section confirmed specific expression of GFP in cells of mesenchymal origin. Green fluorescence was observed throughout the metanephric mesenchyme, ranging from condensed mesenchyme, S-shaped bodies, to renal tubules (Fig. 1B) . This expression pattern is consistent with LacZ expression of Sall1-LacZ knockin mice generated earlier (Fig. 1C) (Nishinakamura et al., 2001) . Sall1 expression was also observed in glomeruli in Sall1-LacZ mice, but not in Sall1-GFP mice perhaps due to the low sensitivity of GFP. Examination of both strains revealed Sall1 expression in stromal cells, the outer most layer of the kidney, that was not noted in our earlier study.
Isolation of GFP-expressing kidney mesenchymal cells by FACS
To isolate GFP-positive cells from embryonic kidneys of these Sall1-GFP heterozygous mice, FACS analysis was used. Embryonic kidneys (17.5 dpc) were digested with collagenase, dissociated into single cells by pipetting and sorted. GFP-positive cells (12% of total kidney cells) and GFP-negative cells (20%) were isolated ( Fig. 2A) , and their purity was determined by reanalysis (94% of isolated GFPpositive cells and 99% of isolated GFP-negative cells were redetected in each gate).
Gene expression of each population was examined using RT-PCR (Fig. 2B) . Indeed the positive population preferentially expressed Sall1, GDNF and WT-1, marker genes of mesenchymal cells, while the negative population preferentially expressed Ret, a marker gene of the ureteric bud. A weak Sall1 signal in the GFP-negative cells indicated that cells weakly expressing Sall1 were included in the GFP-negative gate we defined in FACS analysis.
Demonstration of differential gene expression
To identify genes that are differentially expressed between GFP-positive and -negative populations, microarray analysis with Affymetrix GeneChip probe array was done. One microgram total RNA of each population isolated from the FACS analysis were individually amplified to 50 mg of cRNA by T7-mediated in vitro transcription, and each cRNA product was used to interrogate Mu74 GeneChips containing probe sets representing over 36,000 mouse genes and EST clusters. We identified 392 mRNAs expressed threefold greater in the GFP-positive population and sorted the list by the sort score determined using GeneChip software. The sort score is a ranking on the fold change and the absolute expression intensity. The higher the fold change and the absolute expression intensity become, the higher was the sort score. For example a gene whose absolute expression intensity changes from 100 in GFPnegative cells to 1000 in GFP-positive cells has a higher sort score than a gene whose absolute expression intensity changes from 1 to 10. Thus we obtained a statistical evaluation of differences in expression level of a gene based on the fold change and the absolute expression intensity.
We identified a large number of genes reported to be abundantly expressed in the metanephric mesenchyme, including Sall1 (14-fold), Glial cell line-derived neurotrophic factor (GDNF) (39-fold), Reelin (14-fold), Six-2 (9-fold), Pax-8 (31-fold), LRP-2 (7-fold), PDGFc (11-fold), HeyL (8-fold), Cited-1 (8-fold), Syndecan-4 (17-fold), BMPR-1A (8-fold) WT-1 (7-fold), FGF-10 (3-fold) and BMP-7 (3-fold). We also detected stromal genes such as Raldh-2 (23-fold) and Fox D1 (6-fold), which is consistent with Sall1 expression in this cell population. See supplementary information for the complete data set (Supplementary information 1).
We also examined genes expressed more in GFPnegative cells than in the positive cells. We detected 612 mRNAs expressed threefold weaker in the GFP-positive cells (data not shown). We detected genes which are known to specifically expressed ureteric buds, such as Wnt-11 (11-fold) and TGFb-1 (18-fold). However, many genes expressed in blood vessels were detected in these mRNAs which means that GFP-negative cells include not only ureteric buds but also cells derived from blood vessels.
To verify the result of microarray analysis, we subsequently did in situ hybridization for the top 50, except genes the expression patterns of which were previously Mean: expression intensity of cDNA. Test: (þ) indicates that the cDNA proved to be a mesenchymal gene. (2) indicates that the cDNAs were proven to be negative. Method: Some cDNA were already noted in mesenchymal genes (Reported), and others were identified by mRNA in situ hybridization (in situ).
reported (Table 1 ). The expression patterns of most of the genes were in good correlation with the results of our microarray analysis. 78% of the top 50 was confirmed to be expressed in the condensed mesenchyme, stromal cells, metanephric tubles or glomeruli. Out of top 50 mRNAs, 22 were previously reported as mesenchymal genes, 17 are newly identified ones as mesenchymal genes in the present work and 11 are not expressed in the mesenchyme. This indicates that most of the genes detected in the GFP-positive population using microarray analysis are indeed expressed abundantly in cells of mesenchymal origin or stromal cells.
Expression pattern of novel mesenchymal genes in the developing kidney
To determine which cells of the developing kidney express mesenchymal genes detected by microarray analysis, in situ hybridization with selected mRNAs was 
The expression pattern of each cDNAs was classified based on compartments of the kidney. The cDNAs were listed in order of sort score. The expression levels are represented by: (þ ) abundantly, (2) not detected, (^) weakly, (?) unknown. done (Table 2) . We examined the top 50 mRNAs as well as mRNAs which gave high 'fold change' or high 'absolute expression intensity' in GFP-positive cells. We found that many genes defined as mesenchymal by microarray analysis were indeed expressed in the metanephric mesenchyme, including ALCAM, SSB-4, Smarcd3, m-crystallin, TRB-2. These genes have not been previously reported as mesenchymal genes. In situ hybridization of these genes at two stages is shown in Fig. 3 (Supplementary information 2 for detailed images). 14.5 dpc is the stage representing development of the nephron in process, and 17.5 dpc is the stage at which RNA samples were collected.
ALCAM was first identified on thymic epithelial cells . ALCAM is a member of the Ig superfamily containing five extracellular Ig domains, and it activates leukocytes (Bowen et al., 1995) . Arai et al.
reported that ALCAM-positive perichondrial cells can differentiate into multiple lineages and the addition of ALCAM-Fc to metatarsal cultures inhibits the invasion of the blood vessels to a cartilage (Arai et al., 2002) . We found that ALCAM was expressed abundantly in stromal cells, consisting with Sall1 expression in the stromal region (Fig. 3A,A 0 ). The Raldh2 gene codes for a retinaldehyde dehydrogenase that catalyzes the second oxidative step in the biosynthesis of retinoic acid (RA) from retinol (Zhao et al., 1996) . Raldh2 is responsible for most of the RA-synthesizing activity during early mouse embryogenesis (7.5 -9.5 dpc), as seen from the failure of Raldh2 2 /2 embryos to activate RA-responsive transgenes (Niederreither et al., 1999) . These mutant embryos, which die at E9.5-10.5 from severe cardiac defects, exhibit axial truncation due to impaired somite growth, as well as hindbrain defects 
( Niederreither et al., 1999 Niederreither et al., , 2000 Niederreither et al., , 2001 . Our in situ hybridization showed Raldh2 to be expressed in the stromal region (Fig. 3B ,B 0 ). Identification of two stromal genes (ALCAM and Raldh2) further proves that Sall1 is also expressed in the stromal region.
TRB-2 is a mammalian homolog of Drosophila tribbles, which causes the degradation of String/CDC25 and blocks mitosis. TRB-2 was specifically expressed in the comma-, S-shaped bodies and glomeruli (Fig. 3C,C 0 ). TRB-3 was shown to be involved in insulin signaling (Du et al., 2003) , which was the first demonstration that this family is important in mammals.
m-crystallin is one of the taxon-specific crystallins and the predicted amino acid sequence indicates that m-crystallin might have an enzymatic rather than a structural role in lens tissue (Kim et al., 1992; Vie et al., 1997) . We specifically detected m-crystallin in the condensed mesenchyme of the metanephric kidney (Fig. 3D,D 0 ). Smarcd3 is the member of the SWI/SNF family, the members of which display helicase and ATPase activities and which are thought to regulate transcription of certain genes by altering the chromatin structure around those genes (Ring et al., 1998) . The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI. Our in situ hybridization showed Smarcd3 to be abundantly expressed in the condensed mesenchyme, S-, commashaped bodies and weakly in the ureteric buds and collecting ducts (Fig. 3E,E 0 ). SSB-4 is a member of family of proteins that contain a C-terminal SOCS box and a SPRY domain. SSB-4 was expressed abundantly in the condensed mesenchyme, glomerulus and weakly in ureteric buds and collecting ducts (Fig. 3F,F 0 ). We also examined expression patterns of some ESTs (Fig. 4) . BC023483 was specifically expressed in the condensed mesenchyme (Fig. 4A) . 2810004A10Rik was expressed abundantly in the S-, comma-shaped bodies and weakly in the condensed mesenchyme (Fig. 4B) . 1110038H03Rik was expressed abundantly in S-, commashaped bodies and weakly in the condensed mesenchyme (Fig. 4C) .
Taken together, it is evident that a combination of microarray analysis and Sall1-GFP knockin mice is useful for identification of kidney mesenchymal genes.
Mesenchymal genes in Sall1 knockout mice
This analysis also means that detected genes should colocalize with Sall1 at various stages of metanephric development. The genes detected using our microarray analysis possibly include genes interacting with Sall1, genes downstream or upstream of Sall1, and these candidate genes could be essential for metanephric development. Colocalization of candidate genes with Sall1 allows one to hypothesize that those genes could be regulated by critical transcription factors for kidney development, including Sall1. To clarify whether detected genes are downstream targets of Sall1, in situ hybridization in the developing kidney of Sall1 knockout mice was done (11.5 dpc). At 11.5 dpc, uninduced condensed mesenchyme exists in Sall1 knockout mice, but is reduced in size. We found 10 genes in the top 50 that were expressed in the condensed mesenchyme at 11.5 dpc. In Sall1 knockout mice, expression levels of all the genes were either intact (Six2, Raldh2, PDGFc, ALCAM, Hunk, Gas2, m-crystallin) or reduced (Pax8, Unc4.1, GDNF) (Fig. 5 and data not shown), and no gene was completely absent. Reduction in expression level of some genes could occur by metanephric mesenchymal reduction in size in Sall1 knockout mice (Nishinakamura et al., 2001) . In this case, transcription factors other than Sall1 could regulate the candidate genes, and utilization of mice lacking other critical transcription factors would be needed to clarify genetic cascades involved in candidate genes detected in this present work. Alternatively it could be possible that they are downstream targets of Sall1 and loss of Sall1 is compensated for by other transcription factors or Sall family genes (Sall2, Sall3 and Sall4). To demonstrate this possibility, generating mice lacking both Sall1 and another transcription factor or mice lacking all the Sall family genes is awaited.
Discussion
In the developing kidney, Sall1 is expressed in the stroma region and cells of mesenchymal origin, including condensed mesenchyme, S-, comma-shaped bodies, podocytes, Bowman's capsule and distal, proximal tubles, while cells not expressing Sall1 are collecting ducts, ureteric buds, medullary zone and blood vessels. This means that a comparison analysis of gene expression profiles in Sall1-positive and -negative cells can identify mesenchymal genes. Indeed we could detect many well-known mesenchymal genes using microarray analysis, including GDNF, Raldh-2, Reelin, Six-2, Pax-8, LRP-2, PDGFc, HeyL, Cited-1, Syndecan-4, BMPR-1A, WT-1, FoxD1, FGF-10 and BMP-7. Our in situ hybridization analysis showed that 78% of the top 50 mRNAs of the microarray list were specifically expressed in cells of mesenchymal origin or the stroma. This supports the notion that many mesenchymal genes are enriched in Sall1-positive cells. Moreover we found unknown mesenchymal genes and ESTs that are expressed Raldh2. u, ureteric buds; asterisk ( p ), condensed mesenchyme.
in cells of mesenchymal origin, using in situ hybridization, including m-crystallin, ALCAM, SSB-4, Smarcd3 and TRB-2. Thus we demonstrate that a combination of microarray technology and Sall1-GFP knockin mice is useful for efficient identification of mesenchymal genes expressed in the developing kidney. Though kidney development is indeed a complicated system, no more than 20 genes have been identified as being essential. In this report, we identified a large number of mesenchymal genes in the developing kidney. To find essential genes from this large list, efficient and rapid screening is needed. Recently emerging siRNA technology is one potent method. Indeed Sakai et al. reported that transfection of siRNA into the metanephros followed by organ culture was useful for demonstrating essential roles of fibronectin in the developing kidney (Sakai et al., 2003) . A similar approach could be used for our candidate genes. However, interpretation can be risky. A variety of genes was reported to be essential for kidney development, using conventional antisense oligo nucleotides and organ culture technology, but many proved negative when subjected to gene targeting. Therefore generating knockout mice of each candidate gene is necessary for proof. Establishment of a kidney-specific knockout system could also be useful for the purpose.
We showed that Sall1, GDNF, and Raldh-2, the genes essential for metanephric development, rank high in our gene chip list. GDNF is expressed in the metanephric mesenchyme before ureteric bud initiation. Null mutation of GDNF has severe kidney phenotypes, ranging from no ureteric bud formation to rudimentary kidney formation, which is very close to the phenotype of Sall1 mutant mice. Retinaldehyde dehydrogenase-2 (Raldh2) is required for most embryonic RA synthesis (Niederreither et al., 1999) and is expressed in stromal cells (Fig. 3F,F 0 ). Raldh2, RARa and RARb2 are colocalized in the cortical stroma, and knockout mouse studies showed that RA is important in the cortical stroma for generating signals that control branching morphogenesis by regulating Ret expression in the ureteric bud (Batourina et al., 2001 ). Sall1 could be involved in these GDNF-Ret and/or RA-Ret pathways, though Raldh2 is unlikely to be a downstream target of Sall1, as shown by intact Raldh2 expression in Sall1 knockout mice (Fig. 5C ).
In conclusion, we identified many mesenchymal genes, and demonstrated that using a combination of microarray technology and Sall1-GFP knockin mouse is a pertinent means of identifying mesenchymal genes systematically. A similar approach may be applicable to other organs, such as brains and limb buds where Sall1 is expressed.
Experimental procedures
Generation of GFP knockin mice
A Sal-NotI GFP fragment (769 bp) from pEGFP-N1 (Clontech) was fused to the Sal I-Pac I site of pxCAN-LacZ (RIKEN), then the 5 0 Sma I-Sma I 5.4 kb fragment was fused to the Bam HI site of this vector in frame. Finally, the resultant Sal I-Xho I 6.7 kb fragment was cloned into the Xho I site of the vector, that contained the neomycinresistant (neo r ) gene (pMC1-neo polyA), 3 0 HindIII-Cla I 2.8 kb fragment and a diphtheria toxin A subunit (pMC1-DTA) in tandem.
E14.1 embryonic stem cells were plated on mitomycin C-treated primary embryonic fibroblasts, and clones resistant to G418 (400 mg/ml) were screened using Southern blots. The genomic DNA from clones was digested with HindIII, electrophoresed through 0.7% agarose, transferred to nylon membrane (HybondN þ , Amersham-Pharmacia), and hybridized to a radioactive probe. The probe used to screen the samples was a Cla I-Eco RI 1.2 kb fragment downstream of 3 0 homology (probe B). The samples were also digested with Xho I, and hybridized with a 5 0 probe (probe A) to confirm the correct homologous recombination. A probe corresponding to the Neo sequence was also used to verify that only one copy of the vector was integrated into the genome. Of 120 clones, six were correctly targeted for Sall1-GFP.
Recipient blastocysts were from C57BL/6J mice. Chimeric animals were bred with C57BL/6J females. Mutant animals studied were of F 2 and F 3 generations. Mice were genotyped using Southern blots or genomic PCR. The primer sequences used for PCR were as follows: AGC-TAAAGCTGCCAGAGTGC, CAACTTGCGATT GCCAT AAA, and GCGTTGGCTACCCGTGATAT (288 bp for the wild-type Sall1 allele, and 350 bp for the mutated allele).
Fluorescein-activated cell sorting
Cell suspension was prepared from kidney of Sall1-GFP knockin mice (17.5 dpc). Kidneys were digested with 0.25% collagenase type B (Roche Diagnostics) at 37 8C for 1 h, and cells were dissociated using fine-tipped pipettes. After the cells had been filtered through a 35 mm nylon mesh, they were resuspended in PBS containing 0.5% FCS and 1 mM EDTA at a final concentration of 2 £ 10 6 cells/ml. Propidium Iodide (Sigma-Aldrich) was added at a final concentration of 50 mg/ml to label the dead cells.
FACS analysis was done with the FACS Vantage (Becton Dickinson Immunocytometry Systems). Dead cells were excluded from the plots based on propidium iodide. The isolated cells were centrifuged at 1000 rpm for 5 min and resuspended in TRIzol Reagent (Invitrogen).
RNA amplification for array analysis
MessageAmpe aRNA Kits (Ambion) were used according to the manufacturer's instructions. Briefly, 11 ml of 1 mg total RNA and 1 ml of T7-Oligo(dT) Primer incubated at 70 8C for 10 min, was followed by incubation at 42 8C for 5 min. Next, 2 ml of 10 £ First Strand Buffer, 1 ml of Ribonuclease Inhibitor and 4 ml of dNTP Mix were added, and incubation continued at 42 8C for 2 h. Next, 63 ml of RNase-free H 2 O, 10 ml of 10 £ Second Strand Buffer, 4 ml of dNTP Mix, 2 ml of DNA Polymerase and 1 ml of RNase H, and the mixture was incubated at 16 8C for 2 h. Next, the cDNA was purified, and dried down to 8 ml for in vitro transcription. For in vitro transcription, 8 ml of the purified cDNA, dried biotin-CTP and -UTP, 2 ml of T7 ATP Solution (75 mM), 1.5 ml of T7 CTP Solution (75 mM), 2 ml of T7 GTP Solution (75 mM), 1.5 ml of T7 UTP Solution (75 mM), 2 ml of Enzyme Mix, and 1 ml of RNasefree H 2 O were incubated at 37 8C for 12 h. Then 2 ml of DNase 1 was added and incubated at 37 8C for 30 min, followed by antisense RNA purification.
Microarray analysis
The Affymetrix Murine Genome U74v2 Set was used to compare gene expression profiles of the GFP-positive and -negative cells according to manufacturer's protocols. Briefly, biotinylated cRNAs were synthesized and hybridized to the GeneChip probe arrays, which were then washed in washing solution, stained with streptavidinphycoerythrin and scanned. Analysis was made using Affymetrix GeneChip software. Two independent RNA samples were prepared and similar results were obtained using Mu74A GeneChip, then one of two samples was used for Mu74 complete GeneChip (Mu74A, B and C).
In situ hybridization
In situ hybridization was done using digoxigenin-labeled antisense riboprobes as described (Nishinakamura et al., 2001) . Fragments were amplified using PCR, subcloned into pCRII (Invitrogen), and sequenced. None of the sense probes yielded signals.
